Certain Transactions (Details) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|---|
Nov. 01, 2021 |
Feb. 16, 2021 |
Dec. 31, 2019 |
Jun. 30, 2019 |
Dec. 31, 2018 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Jun. 02, 2020 |
|
Certain Transactions (Details) [Line Items] | |||||||||
Aggregate purchase price | $ 97,100 | ||||||||
Exchange agreement description | In exchange for 100% of the outstanding shares of Origin the Company issued 1,488 thousand ordinary shares, paid cash upon closing and is obligated to pay additional payments (combination of cash and shares) subject to performance-based earnouts over 3 years. | ||||||||
Description of contingent payments | The total contingent payments could reach to a maximum aggregate amount of up to $40 million. Approximately 50% of the payments shall be settled in cash, and 50% shall be settled through the issuance of ordinary shares. | ||||||||
Additional payment amount | $ 6,000 | ||||||||
Retention period | 3 years | ||||||||
Compensation expenses. | $ 4,300 | ||||||||
Intangible asset | $ 45,000 | ||||||||
Intangible asset useful-life | 7 years | ||||||||
Aggregate purchase price | $ 29,300 | ||||||||
Additional earn-out payment | 15 years | ||||||||
Fair value | $ 23,800 | ||||||||
Gain | 14,400 | ||||||||
Foreign currency gain | 600 | ||||||||
Total contingent payments aggregate amount | 21,000 | ||||||||
Liability amount | 14,000 | ||||||||
Exchange for outstanding shares, percentage | 100.00% | ||||||||
Based earn-outs over term | 2 years | ||||||||
Changes in fair value of equity investment | 600 | ||||||||
Net gain on divestiture of minority interest | 1,301 | ||||||||
Restructuring plan, percentage | 10.00% | ||||||||
Employee related charges | 6,400 | ||||||||
Other related charges | $ 3,900 | ||||||||
XAAR [Member] | |||||||||
Certain Transactions (Details) [Line Items] | |||||||||
Remaining acquire share, percentage | 55.00% | ||||||||
Consideration paid | 29,281 | ||||||||
Related to Developed Technology [Member] | |||||||||
Certain Transactions (Details) [Line Items] | |||||||||
Intangible asset | $ 71,000 | ||||||||
Intangible asset useful-life | 10 years | ||||||||
XAAR [Member] | |||||||||
Certain Transactions (Details) [Line Items] | |||||||||
Investment, description | the Company entered into an agreement with Xaar plc (“Xaar”) to purchase additional shares of Xaar 3D that will increase its stake from 15 to 45 percent, with Xaar retaining the remaining 55 percent. | ||||||||
Additional interest amount | $ 15,700 | ||||||||
LPW Technology [Member] | |||||||||
Certain Transactions (Details) [Line Items] | |||||||||
Consideration paid | $ 3,600 | ||||||||
Unconsolidated Entity [Member] | |||||||||
Certain Transactions (Details) [Line Items] | |||||||||
Net gain on divestiture of minority interest | $ 11,800 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Additional payment amount. No definition available.
|
X | ||||||||||
- Definition Amount of Aggregate purchase price. No definition available.
|
X | ||||||||||
- Definition Based earnouts over term. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Changes in fair value of equity investment. No definition available.
|
X | ||||||||||
- Definition Amount of compensation expenses. No definition available.
|
X | ||||||||||
- Definition Description of Contingent payments. No definition available.
|
X | ||||||||||
- Definition Exchange agreement description. No definition available.
|
X | ||||||||||
- Definition Exchange for outstanding shares, percentage. No definition available.
|
X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Restructuring plan, percentage. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Total contingent payments aggregate amount. No definition available.
|
X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Description of expense limitation agreement. Includes, but is not limited to, term of carryover expense and expense in excess of expense limitation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liability position for contract or contract feature in long-duration contract issued by insurance entity that both protects contract holder from other-than-nominal capital market risk and exposes insurance entity to other-than-nominal capital market risk. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The cash outflow associated with the purchase of noncontrolling interest during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|